Clinical Trial Update: Value of Inhaled Treatment With Aztreonam Lysine in Bronchiectasis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating inhaled aztreonam lysine for bronchiectasis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiectasis

Drugs mentioned

• Aztreonam lysine for inhalation (Cayston) (Aztreonam lysine for inhalation)

Snippet

Sponsor: University of Dundee | Conditions: Bronchiectasis Adult | Phase 4 | Status: TERMINATED